ClinicalTrials.Veeva

Menu

Tragal Perichondrium Versus Pretragal Fascial (SMAS) Graft for Endoscopic Myringoplasty

A

Assiut University

Status

Unknown

Conditions

Tympanic Membrane Perforation

Treatments

Procedure: Endoscopic myringoplasty

Study type

Interventional

Funder types

Other

Identifiers

NCT04687995
Endoscopic myringoplasty

Details and patient eligibility

About

  1. Examine the treatment outcomes of the pretragal (SMAS) fascia as a new graft when used in endoscopic myringoplasty.
  2. Compare the results when using the tragal pericondrium as a graft in endoscopic myringoplasty regarding donor site and success.

Full description

The exclusive transcanal endoscopic tympanoplasty technique emerged in the1990s : it provides a more direct and wider surgical viewing angle, largely reduces the necessity for a traumatic postauricular incision. Some otolgists have adopted this technique using the nearby tragal perichondrium/cartilage graft. The tragus has a pivotal function in reconstruction in ear surgery. The superficial musculoaponeurotic system (SMAS) was first introduced by Mits and Peyroniein1976. It is located in the mid-face overlying the parotid gland and mimic muscles, It connects the dermis and the muscles, acting as a unique motor unit to produce facial expressions. The SMAS graft has great potential because it is accessible from the least invasive transcanal route of tympanoplasty, and is located away from the vital structures.

Enrollment

40 estimated patients

Sex

All

Ages

16 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Above 16 yrs old and less than 50 yrs old.
  2. Clinically diagnosed central tympanic membrane perforations or chronic suppurative otitis media (tubo-tympanic).
  3. Dry ear: no otorrhea without medication for at least 1 month.
  4. Hearing loss gap not more than 50dB

Exclusion criteria

  1. Age less than 16 or more than 50.
  2. Discharging (active) central perforations.
  3. Unsafe CSOM with cholesteatoma.
  4. Suspected ossicular pathology in safe CSOM if the gap > 50dB.
  5. Previous ear surgery.
  6. Patients unfit for surgery or having chronic medical illness.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Tragal preichondrium graft
Active Comparator group
Description:
Tragal perichodrium graft for endoscopic myringoplasty as a reference graft
Treatment:
Procedure: Endoscopic myringoplasty
pretragal ( SMAS) fascia graft
Active Comparator group
Description:
pretragal ( SMAS) fascia graft for endoscopic myringoplasty as a new graft
Treatment:
Procedure: Endoscopic myringoplasty

Trial contacts and locations

0

Loading...

Central trial contact

Mahmoud Mohamed Ragheb, Professor; Hazem Gamal Noreldin, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems